Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer

Distant metastases is the leading cause of differentiated thyroid cancer-related death. Radioactive iodine (RAI) treatment is the most effective therapy for RAI-avid metastatic differentiated

  • 0 views
  • 16 May, 2021
  • 2 locations
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

cancers (DTC) with iodine-avid metastases. The investigators hypothesize that precise dosimetric planning will permit this combined RAI-XRT radiotherapeutic approach to be safe and permit higher tumor

  • 0 views
  • 31 May, 2021
  • 1 location
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Background About 5% to 10% of differentiated thyroid cancers become resistant to standard treatment with radioactive iodine. In these cases, treatment options are limited and generally not effective. Researchers want to see if they can better detect thyroid tumors by using a compound called 68Gallium-DOTATATE. This compound may bind to …

  • 0 views
  • 23 May, 2022
  • 1 location
Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Health-ITUEM), the proposed project will refine and test a next-generation diagnostic intervention …

HIV Vaccine
AIDS
Accepts healthy volunteers
hiv test
  • 23 views
  • 26 Feb, 2022
  • 1 location
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

This phase III trial studies iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Crizotinib may stop the growth of tumor cells by blocking …

busulfan
bone marrow procedure
tumor cells
catecholamines
shortening fraction
  • 117 views
  • 01 Mar, 2022
  • 102 locations
18F-DOPA II - PET Imaging Optimization

A single centre non-randomized, non-blinded phase III prospective cohort study of 18F-DOPA PET/CT imaging in specific patient populations: Pediatric patients (less than 18 years old) with congenital hyperinsulinism. Pediatric patients (less than 18 years old) with neuroblastoma. Pediatric (less than 18 years old) or Adult patients (18 or older) with …

parkinson's disease
dopa
dementia
  • 0 views
  • 03 May, 2022
  • 1 location
'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL

This is a single-arm open-label phase I/II trial studying the safety and efficacy of focal 're-priming' radiation therapy (RT) to FDG-avid residual sites of disease in relapsed/refractory non

follicular lymphoma
large b-cell lymphoma
b-cell lymphoma
diffuse large b-cell lymphoma
refractory non-hodgkin's lymphoma
  • 0 views
  • 22 Mar, 2022
  • 1 location
Brazilian Total Neoadjuvant Therapy Trial

-radiation and no tumor can be found in the surgical specimen. These patients can be followed with close surveillance and avid surgery. The aim of this study is to evaluate if a strategy including the use of

  • 0 views
  • 27 Oct, 2021
  • 1 location
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone (ARROW)

enzalutamide alone in participants with prostate-specific membrane antigen (PSMA)-avid metastatic castration resistant prostate cancer (mCRPC) who have progressed on abiraterone. Participants must be

pet/ct
cancer
serum testosterone
taxane
soft tissue disease
  • 74 views
  • 09 Feb, 2022
  • 25 locations
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

objective of this study is to compare the 124 I -PET/CT lesional and whole body dosimetry in each individual patient with metastatic radioiodine (RAI)-avid thyroid cancer under preparation with rhTSH and

thyrotropin
recurrent disease
avid
cancer
thyroid hormones
  • 13 views
  • 25 May, 2022
  • 1 location